The U.S. government is easing some rules on medical marijuana, reclassifying it from a Schedule 1 to a Schedule 3 drug, a ...

Following the recent drug rescheduling from the Trump Administration, medicinal marijuana companies are preparing to raise ...

State leaders expect tax breaks for medical marijuana businesses to be the biggest boon as the Department of Justice moves to ...

My stance on this issue has been clear. I remain committed to combatting the growing public health and safety threat ...

By Puyaan Singh and Christy Santhosh April 30 (Reuters) - Companies developing cannabis-based medicines say U.S. moves to ...

The order places FDA-approved products containing marijuana and state-regulated medical marijuana products at a lower drug ...